Kymera Therapeutics, Inc. (KYMR)
131.73
+3.61
(+2.82%)
USD |
NASDAQ |
Nov 06, 16:00
131.70
-0.03
(-0.02%)
After-Hours: 20:00
Kymera Therapeutics Total Assets (Quarterly) : 1.767B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.767B |
| June 30, 2026 | 1.645B |
| March 31, 2026 | 1.669B |
| December 31, 2025 | 1.743B |
| September 30, 2025 | 1.102B |
| June 30, 2025 | 1.131B |
| March 31, 2025 | 918.31M |
| December 31, 2024 | 978.04M |
| September 30, 2024 | 1.035B |
| June 30, 2024 | 826.02M |
| March 31, 2024 | 868.25M |
| December 31, 2023 | 575.76M |
| September 30, 2023 | 552.38M |
| June 30, 2023 | 581.94M |
| Date | Value |
|---|---|
| March 31, 2023 | 613.90M |
| December 31, 2022 | 603.13M |
| September 30, 2022 | 638.47M |
| June 30, 2022 | 523.42M |
| March 31, 2022 | 563.06M |
| December 31, 2021 | 605.90M |
| September 30, 2021 | 642.45M |
| June 30, 2021 | 434.39M |
| March 31, 2021 | 464.55M |
| December 31, 2020 | 487.18M |
| September 30, 2020 | 507.36M |
| June 30, 2020 | 181.11M |
| March 31, 2020 | |
| December 31, 2019 | 116.70M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 902.56M |
| Twist Bioscience Corp. | 672.44M |
| Beam Therapeutics, Inc. | 1.269B |
| C4 Therapeutics, Inc. | 331.80M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 152.74M |
| Shareholders Equity (Quarterly) | 1.615B |
| Debt to Equity Ratio | 0.0474 |
| Current Ratio | 11.13 |
| Net Debt Paydown Yield | 0.02% |